Clinical Trial Update: Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma [NA]

View source ↗

Summary

This clinical trial update covers a study of Brentuximab Vedotin in combination with AVD chemotherapy for newly diagnosed early-stage, unfavorable-risk Hodgkin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)
• Dacarbazine (dacarbazine)
• Doxorubicin (doxorubicin)
• Vinblastine (vinblastine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hodgkin Lymphoma | NA | Status: ACTIVE_NOT_RECRUITING